Skip to main content
OpenTrials

Clinical trial condition

Infections, Herpesviridae

Explore clinical trials studying Infections, Herpesviridae. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Infections, Herpesviridae trial results

Completed

VALTREX Once Daily For Viral Shedding In Herpes Simplex Virus 2 (HSV-2) Seropositive Subjects. VALTREX® Tablet is a Trademark of GlaxoSmithKline Group of Companies.

NCT00116844

Conditions
Communicable Diseases, DNA Virus Infections, Disease Attributes, +22 more
Locations
  • GSK Investigational Site Carmichael, California, United States
  • GSK Investigational Site Davis, California, United States
  • GSK Investigational Site Riverside, California, United States
  • GSK Investigational Site Sacramento, California, United States
View all 17 locations
View Trial Details

Related conditions